1
Total investments
1
Early stage
0
Mid stage
0
Late stage
8y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Jun 2018
Sonic Incytes is committed to enhancing patient care through innovative diagnostic solutions. The companys flagship product, Velacur™, equips physicians with an advanced liver imaging tool to help manage the growing epidemic of fatty liver disease. Velacur offers real-time, AI guided quantification of the two key markers for fatty liver disease: liver stiffness and attenuation. With real-time results, a low up-front cost and AI guidance, VELACUR makes liver imaging at the point of care affordable and accessible.
Experience · 2 entries
All (2)
Investments (1)
Founder (1)
Board (1)
2020
Co-Founder
Feb 2020
Full spectrum respiratory support solutions for COVID. We aim to provide low-cost ventilators and PPE that are open-source and accessible to the general public.
2018
Board Member
Jun 2018
Sonic Incytes is committed to enhancing patient care through innovative diagnostic solutions. The companys flagship product, Velacur™, equips physicians with an advanced liver imaging tool to help manage the growing epidemic of fatty liver disease. Velacur offers real-time, AI guided quantification of the two key markers for fatty liver disease: liver stiffness and attenuation. With real-time results, a low up-front cost and AI guidance, VELACUR makes liver imaging at the point of care affordable and accessible.